Cargando…
Physiological Impact of Abnormal Lipoxin A(4) Production on Cystic Fibrosis Airway Epithelium and Therapeutic Potential
Lipoxin A(4) has been described as a major signal for the resolution of inflammation and is abnormally produced in the lungs of patients with cystic fibrosis (CF). In CF, the loss of chloride transport caused by the mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) Cl(−) cha...
Autores principales: | Higgins, Gerard, Ringholz, Fiona, Buchanan, Paul, McNally, Paul, Urbach, Valérie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383482/ https://www.ncbi.nlm.nih.gov/pubmed/25866809 http://dx.doi.org/10.1155/2015/781087 |
Ejemplares similares
-
The role of Lipoxin A4 in Cystic Fibrosis Lung Disease
por: Urbach, Valérie, et al.
Publicado: (2013) -
Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium
por: Al‐Alawi, Mazen, et al.
Publicado: (2014) -
Lipoxin A(4) Stimulates Calcium-Activated Chloride Currents and Increases Airway Surface Liquid Height in Normal and Cystic Fibrosis Airway Epithelia
por: Verrière, Valia, et al.
Publicado: (2012) -
Lower Airway Infection in Preschool Children with Cystic Fibrosis: An International Comparison
por: Hulme, Kathryn M., et al.
Publicado: (2020) -
The Microbial Community of the Cystic Fibrosis Airway Is Disrupted in Early Life
por: Renwick, Julie, et al.
Publicado: (2014)